TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer’s Disease
The microglial receptors CD33 and TREM2 have been associated with risk for Alzheimer’s disease (AD). Here, we investigated crosstalk between CD33 and TREM2. We showed that knockout of CD33 attenuated amyloid beta (Aβ) pathology and improved cognition in 5xFAD mice, both of which were abrogated by ad...
Saved in:
Published in | Neuron (Cambridge, Mass.) Vol. 103; no. 5; pp. 820 - 835.e7 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
04.09.2019
Elsevier Limited |
Subjects | |
Online Access | Get full text |
ISSN | 0896-6273 1097-4199 1097-4199 |
DOI | 10.1016/j.neuron.2019.06.010 |
Cover
Loading…